Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia

NCT03464682 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: HS-25 10mg
DRUG: HS-25 10mg combination with Atorvastatin
DRUG: HS-25 20mg combination with Atorvastatin
DRUG: Atorvastatin 10mg
DRUG: HS-25 20mg
DRUG: Placebe of HS-25 and Atorvastatin

Sponsor

Zhejiang Hisun Pharmaceutical Co. Ltd.